ProfileGDS4718 / 216107_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 63% 66% 59% 68% 65% 61% 66% 69% 67% 57% 62% 62% 66% 62% 62% 59% 62% 64% 67% 73% 64% 61% 58% 58% 64% 63% 60% 65% 63% 69% 67% 60% 67% 60% 61% 61% 60% 69% 66% 57% 63% 65% 64% 60% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.3455863
GSM549102patient 115, normal, homogenized [OPG study]6.5282466
GSM549104patient 119, normal, homogenized [OPG study]6.0637659
GSM549108patient 138, normal, homogenized [OPG study]6.6644468
GSM549119patient 077, normal, homogenized [OPG study]6.4837765
GSM549133patient 032, cancer, homogenized [OPG study]6.1962461
GSM549139patient 042, cancer, homogenized [OPG study]6.5315866
GSM549099patient 107, normal, homogenized [OPG study]6.7826869
GSM549109patient 139, normal, homogenized [OPG study]6.5890267
GSM549110patient 046, normal, homogenized [OPG study]5.9556657
GSM549114patient 063, normal, homogenized [OPG study]6.2104562
GSM549122patient 082, normal, homogenized [OPG study]6.3101362
GSM549134patient 033, cancer, homogenized [OPG study]6.5210866
GSM549136patient 036, cancer, homogenized [OPG study]6.2598862
GSM549140patient 044, cancer, homogenized [OPG study]6.2748762
GSM549111patient 047, normal, homogenized [OPG study]6.066959
GSM549113patient 057, normal, homogenized [OPG study]6.2193262
GSM549132patient 031, cancer, homogenized [OPG study]6.3815664
GSM549137patient 038, cancer, homogenized [OPG study]6.6844567
GSM549142patient 047, cancer, homogenized [OPG study]7.0663773
GSM549100patient 110, normal, homogenized [OPG study]6.3801464
GSM549107patient 135, normal, homogenized [OPG study]6.1352761
GSM549115patient 068, normal, homogenized [OPG study]5.9867758
GSM549116patient 072, normal, homogenized [OPG study]6.0056658
GSM549120patient 078, normal, homogenized [OPG study]6.3980564
GSM549131patient 030, cancer, homogenized [OPG study]6.3034363
GSM549118patient 074, normal, homogenized [OPG study]6.1141560
GSM549129patient 027, cancer, homogenized [OPG study]6.5472565
GSM549123patient 088, normal, homogenized [OPG study]6.3302863
GSM549124patient 006, cancer, homogenized [OPG study]6.7951569
GSM549126patient 015, cancer, homogenized [OPG study]6.5926667
GSM549128patient 025, cancer, homogenized [OPG study]6.1352560
GSM549103patient 117, normal, homogenized [OPG study]6.5892667
GSM549117patient 073, normal, homogenized [OPG study]6.0770760
GSM549138patient 041, cancer, homogenized [OPG study]6.2338161
GSM549141patient 045, cancer, homogenized [OPG study]6.2122361
GSM549130patient 028, cancer, homogenized [OPG study]6.1309660
GSM549101patient 111, normal, homogenized [OPG study]6.824169
GSM549105patient 128, normal, homogenized [OPG study]6.5468566
GSM549106patient 134, normal, homogenized [OPG study]5.8989157
GSM549112patient 048, normal, homogenized [OPG study]6.3211863
GSM549125patient 011, cancer, homogenized [OPG study]6.4864365
GSM549127patient 024, cancer, homogenized [OPG study]6.4355864
GSM549135patient 035, cancer, homogenized [OPG study]6.082460